MNA
EW icon

Manning & Napier Advisors’s Edwards Lifesciences EW Stock Holding History

Manning & Napier Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.11K Buy
67
+15
+29% +$1.26K ﹤0.01% 569
2026
Q1 		$4.13K Buy
52
+29
+126% +$2.39K ﹤0.01% 524
2025
Q4 		$1.98K Buy
+23
New +$1.89K ﹤0.01% 490

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Manning & Napier Advisors's EW Position: Q2 2026 in Review

Manning & Napier Advisors increased its Edwards Lifesciences (EW) stake by 29% in Q2 2026, buying an estimated $1.26K and bringing the position to 67 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Manning & Napier Advisors first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Manning & Napier Advisors held 67 shares of Edwards Lifesciences worth $6.11K as of Q2 2026.
  • Manning & Napier Advisors bought 15 Edwards Lifesciences shares in Q2 2026, an estimated $1.26K.
  • Edwards Lifesciences made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #569 holding.
  • Manning & Napier Advisors first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.